Maker of Emergen-C , #1
U.S. Vitamin C brand, expands Pfizer's vitamin and dietary supplement
Pfizer Inc. (NYSE:PFE) today announced the acquisition of privately-held
Alacer Corp., the maker and distributor of Emergen-C products, the
largest selling branded Vitamin C line in the United States.
Based in Foothill Ranch, California, Alacer is well-known among
health-conscious consumers as a provider of Vitamin C supplement
products. It produces almost 500 million packets of Emergen-C annually,
and its products are sold in health food stores, supermarkets, drug
stores, mass merchandisers and club stores nationwide.
"We are very pleased that the Emergen-C family of products will become
part of Pfizer's portfolio. We expect that our global network and deep
expertise in dietary supplements combined with our desire to provide
consumers with high-quality products will make Emergen-C more accessible
than it has ever been before," said Paul Sturman, President of Pfizer
Consumer Healthcare. "Emergen-C products add to and greatly complement
our market-leading dietary supplement portfolio."
Emergen-C is an effervescent, powdered drink mix vitamin supplement that
supports active and healthy lifestyles. Available in more than 15
flavors, each of the seven lines of Emergen-C is packed with nutrients,
Vitamins C and B, electrolytes and antioxidants. Specialty formulations
include Emergen-C Kidz® designed specifically for children,
and specialty formulas that support specific health needs such as joint
health and heart health.
"Today marks the beginning of an exciting new chapter for Alacer and the
Emergen-C health and wellness brand. It is a unique opportunity to join
one of the world's top performing consumer health care businesses," said
Ron Fugate, President and CEO of Alacer. "By becoming part of Pfizer, we
can access the resources and reach that will help us support healthy,
active lifestyles across the globe."
Financial terms of the transaction were not disclosed. Lazard acted as
financial advisor to Pfizer, and DLA Piper LLP (U.S.) acted as legal
advisor to Pfizer, in connection with the acquisition. Houlihan Lokey
acted as financial advisor to the owners of Alacer Corp., and Rutan &
Tucker LLP acted as legal advisor to the owners of Alacer Corp., in
connection with the transaction.
Pfizer Inc.: Working together for a healthier world™
At Pfizer, we apply science and our global resources to improve health
and well-being at every stage of life.